OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide

Meletios Dimopoulos, MD, of the University of Athens School of Medicine, Athens, Greece, gives an overview of the OPTIMISMM trial (NCT01734928) at the 2018 Society of Hematologic Oncology (SOHO) Annua... Author: VJHemOnc Added: 09/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts